226 related articles for article (PubMed ID: 11343385)
21. Platelet functional defects in women with unexplained menorrhagia.
Philipp CS; Dilley A; Miller CH; Evatt B; Baranwal A; Schwartz R; Bachmann G; Saidi P
J Thromb Haemost; 2003 Mar; 1(3):477-84. PubMed ID: 12871453
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
[TBL] [Abstract][Full Text] [Related]
23. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
[TBL] [Abstract][Full Text] [Related]
24. What have we learned from large population studies of von Willebrand disease?
Montgomery RR; Flood VH
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):670-677. PubMed ID: 27913545
[TBL] [Abstract][Full Text] [Related]
25. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function.
Nummi V; Lassila R; Joutsi-Korhonen L; Armstrong E; Szanto T
Int J Lab Hematol; 2018 Jun; 40(3):304-311. PubMed ID: 29427305
[TBL] [Abstract][Full Text] [Related]
27. Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization.
Casonato A; Pontara E; Sartorello F; Bertomoro A; Durante C; Girolami A
J Lab Clin Med; 2001 Jan; 137(1):70-6. PubMed ID: 11150026
[TBL] [Abstract][Full Text] [Related]
28. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
29. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
30. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
Hubbard AR; Rigsby P; Barrowcliffe TW
Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
[TBL] [Abstract][Full Text] [Related]
31. Platelet-type von Willebrand disease platelet aggregating factor: a novel functional assay of von Willebrand factor.
Takahashi H; Tatewaki W; Hanano M; Shibata A
Thromb Res; 1987 Nov; 48(4):475-85. PubMed ID: 3127926
[TBL] [Abstract][Full Text] [Related]
32. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
Tosetto A; Rodeghiero F; Castaman G; Bernardi M; Bertoncello K; Goodeve A; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
J Thromb Haemost; 2007 Apr; 5(4):715-21. PubMed ID: 17408405
[TBL] [Abstract][Full Text] [Related]
33. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
[TBL] [Abstract][Full Text] [Related]
34. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
35. Current and emerging approaches for assessing von Willebrand disease in 2016.
Federici AB
Int J Lab Hematol; 2016 May; 38 Suppl 1():41-9. PubMed ID: 27426859
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.
Favaloro EJ
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):553-64. PubMed ID: 21885953
[TBL] [Abstract][Full Text] [Related]
37. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.
Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A
Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334
[TBL] [Abstract][Full Text] [Related]
38. Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease.
Favaloro EJ; Koutts J
Pathology; 1997 Nov; 29(4):385-91. PubMed ID: 9423220
[TBL] [Abstract][Full Text] [Related]
39. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.
Verfaillie CJ; De Witte E; Devreese KM
Int J Lab Hematol; 2013 Oct; 35(5):555-65. PubMed ID: 23551532
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of the DDAVP infusion test with PFA-100 and vWF activity assays to distinguish vWD types in children.
Akin M; Karapinar DY; Balkan C; Ay Y; Kavakli K
Clin Appl Thromb Hemost; 2011 Oct; 17(5):441-8. PubMed ID: 20460340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]